SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-04-003347
Filing Date
2004-11-10
Accepted
2004-11-10 16:32:30
Documents
7
Period of Report
2004-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K b402090_10k.txt 10-K 486628
2 SUBSIDIARIES OF GENEREX BIOTECHNOLOGY b402090_ex21.txt EX-21 549
3 CONSENT OF INDEPENDENT REG. CHARTERED ACCTS. b402090_ex231.txt EX-23.1 755
4 CONSENT OF INDEPENDENT REG. CHARTERED ACCOUNTANTS b402090_ex232.txt EX-23.2 645
5 CERTIFICATION OF ANNA E. GLUSKIN b402090_ex311.txt EX-31.1 3652
6 CERTIFICATION OF ROSE C. PERRI b402090_ex312.txt EX-31.2 3651
7 EXHIBIT 32 ex32.txt EX-32 1489
  Complete submission text file 0000950116-04-003347.txt   499747
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 041133504
SIC: 2834 Pharmaceutical Preparations